L3 Structural and functional proton MRI assessment of cystic fibrosis lung disease in people with F508-del mutation

IntroductionNewer proton MRI methods may be complementary to conventional respiratory diagnostics like computed tomography (CT) and spirometry. Non-contrast Ultrashort Echo Time (UTE) MRI acquires high resolution structural images, comparable to CT, and gradient-echo combined with phase-resolved fun...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thorax 2021-02, Vol.76 (Suppl 1), p.A231-A232
Hauptverfasser: Brooke, J, Safavi, S, Prayle, AP, Ng, C, Alappadan, J, Bradley, C, Cooper, A, Munidasa, S, Zanette, B, Santyr, GE, Barr, H, Major, G, Smyth, A, Gowland, P, Francis, S, Hall, IP
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A232
container_issue Suppl 1
container_start_page A231
container_title Thorax
container_volume 76
creator Brooke, J
Safavi, S
Prayle, AP
Ng, C
Alappadan, J
Bradley, C
Cooper, A
Munidasa, S
Zanette, B
Santyr, GE
Barr, H
Major, G
Smyth, A
Gowland, P
Francis, S
Hall, IP
description IntroductionNewer proton MRI methods may be complementary to conventional respiratory diagnostics like computed tomography (CT) and spirometry. Non-contrast Ultrashort Echo Time (UTE) MRI acquires high resolution structural images, comparable to CT, and gradient-echo combined with phase-resolved functional lung (PREFUL) processing methods can produce spatial assessments of lung function. The need for such MRI methods is exemplified by cystic fibrosis (CF), where rapid development of novel therapeutics demands an equivalent change in our ability to monitor lung disease.AimTo evaluate lung structure and function using UTE and PREFUL MRI methods in people with CF with at least one F508-del mutation pre-Trikafta therapy.Methods5 people with CF (12–21 years; n=4 homozygous F508-del; n=3 on Symkevi) underwent a single MRI scanning session performed on a 3T Philips Ingenia scanner. UTE-MRI was collected during a 10-second breath-hold (n=2) or free breathing with a respiratory-gated acquisition (n=3). PREFUL-MRI was performed using a continuous single coronal slice Fast Field Echo acquisition during 2 minutes of free breathing (n=5).PREFUL analysis was performed using a semiautomated k-means segmentation algorithm in MATLAB. 1 A region of interest (ROI) at the diaphragm was defined, images with extremes of signal intensity were removed and those remaining sorted into a sinusoidal pattern of signal intensity within the ROI. Thoracic masking and a pulmonary vessel filter were applied followed by k-means clustering analysis to demonstrate normal ventilation and ventilation defect. Ventilation defect percentage (VDP) was calculated by dividing the ventilation defect volume by the lung mask volume.ResultsMRI scanning was well-tolerated and both UTE and PREFUL acquisitions were completed in all participants. VDP values ranged from 8.09–36.65%, with the individual with the lowest FEV1 having the highest VDP (figure 1).Abstract L3 Figure 1UTE (left) and PREFUL (right) images from five people with CF. PREFUL MRI shows areas of normal ventilation (green) and ventilation defect (purple).DiscussionOur findings demonstrate the feasibility of combined structural and functional lung MRI assessment in people with CF. These non-contrast approaches do not require additional specialised equipment, such as hyperpolarised gas, and could be obtained using standard clinical MRI scanners. In the future, functional lung MRI may facilitate longitudinal assessment of response to disease mod
doi_str_mv 10.1136/thorax-2020-BTSabstracts.405
format Article
fullrecord <record><control><sourceid>proquest_bmj_p</sourceid><recordid>TN_cdi_proquest_journals_2479616043</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2479616043</sourcerecordid><originalsourceid>FETCH-LOGICAL-b763-f1e816f404e186689804c8008bb3331466419e9a71a04216774741bda69a30243</originalsourceid><addsrcrecordid>eNpNkM1KAzEUhYMoWKvvENBt6s0kTTJLLVYLFcF2HzIzGZsynRnzg3bnxhf1SZxSF64uFw6H830I3VCYUMrEbdx03nySDDIg9-uVKUL0poxhwmF6gkaUC0VYlotTNALgQAST4hxdhLAFAEWpHKG0ZD9f36voUxmTNw02bYXr1JbRde3w9r6LXYufXxfYhGBD2Nk24q7G5T5EV-LaFb4LLuAmtW-4csGaYLFrcW-7vrH4w8UNnk9Bkco2eJeiORRforPaNMFe_d0xWs8f1rMnsnx5XMzulqSQgpGaWkVFzYFbqoRQuQJeqmF5UTDGBjrBaW5zI6kBnlEhJZecFpURuWGQcTZG18fageI92RD1tkt-wAo64zIXVABnQ0oeU8Vuq3vvdsbvNQV9UKyPivVBsf6vWA-K2S-_ynVm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2479616043</pqid></control><display><type>article</type><title>L3 Structural and functional proton MRI assessment of cystic fibrosis lung disease in people with F508-del mutation</title><source>Alma/SFX Local Collection</source><creator>Brooke, J ; Safavi, S ; Prayle, AP ; Ng, C ; Alappadan, J ; Bradley, C ; Cooper, A ; Munidasa, S ; Zanette, B ; Santyr, GE ; Barr, H ; Major, G ; Smyth, A ; Gowland, P ; Francis, S ; Hall, IP</creator><creatorcontrib>Brooke, J ; Safavi, S ; Prayle, AP ; Ng, C ; Alappadan, J ; Bradley, C ; Cooper, A ; Munidasa, S ; Zanette, B ; Santyr, GE ; Barr, H ; Major, G ; Smyth, A ; Gowland, P ; Francis, S ; Hall, IP</creatorcontrib><description>IntroductionNewer proton MRI methods may be complementary to conventional respiratory diagnostics like computed tomography (CT) and spirometry. Non-contrast Ultrashort Echo Time (UTE) MRI acquires high resolution structural images, comparable to CT, and gradient-echo combined with phase-resolved functional lung (PREFUL) processing methods can produce spatial assessments of lung function. The need for such MRI methods is exemplified by cystic fibrosis (CF), where rapid development of novel therapeutics demands an equivalent change in our ability to monitor lung disease.AimTo evaluate lung structure and function using UTE and PREFUL MRI methods in people with CF with at least one F508-del mutation pre-Trikafta therapy.Methods5 people with CF (12–21 years; n=4 homozygous F508-del; n=3 on Symkevi) underwent a single MRI scanning session performed on a 3T Philips Ingenia scanner. UTE-MRI was collected during a 10-second breath-hold (n=2) or free breathing with a respiratory-gated acquisition (n=3). PREFUL-MRI was performed using a continuous single coronal slice Fast Field Echo acquisition during 2 minutes of free breathing (n=5).PREFUL analysis was performed using a semiautomated k-means segmentation algorithm in MATLAB. 1 A region of interest (ROI) at the diaphragm was defined, images with extremes of signal intensity were removed and those remaining sorted into a sinusoidal pattern of signal intensity within the ROI. Thoracic masking and a pulmonary vessel filter were applied followed by k-means clustering analysis to demonstrate normal ventilation and ventilation defect. Ventilation defect percentage (VDP) was calculated by dividing the ventilation defect volume by the lung mask volume.ResultsMRI scanning was well-tolerated and both UTE and PREFUL acquisitions were completed in all participants. VDP values ranged from 8.09–36.65%, with the individual with the lowest FEV1 having the highest VDP (figure 1).Abstract L3 Figure 1UTE (left) and PREFUL (right) images from five people with CF. PREFUL MRI shows areas of normal ventilation (green) and ventilation defect (purple).DiscussionOur findings demonstrate the feasibility of combined structural and functional lung MRI assessment in people with CF. These non-contrast approaches do not require additional specialised equipment, such as hyperpolarised gas, and could be obtained using standard clinical MRI scanners. In the future, functional lung MRI may facilitate longitudinal assessment of response to disease modifying therapies, such as CFTR modulators.ReferenceCouch, et al. Academic Radiology 2020. doi:10.1016/j.acra.2020.05.008.</description><identifier>ISSN: 0040-6376</identifier><identifier>EISSN: 1468-3296</identifier><identifier>DOI: 10.1136/thorax-2020-BTSabstracts.405</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><subject>Cystic fibrosis ; Lung diseases ; Ventilation</subject><ispartof>Thorax, 2021-02, Vol.76 (Suppl 1), p.A231-A232</ispartof><rights>Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Brooke, J</creatorcontrib><creatorcontrib>Safavi, S</creatorcontrib><creatorcontrib>Prayle, AP</creatorcontrib><creatorcontrib>Ng, C</creatorcontrib><creatorcontrib>Alappadan, J</creatorcontrib><creatorcontrib>Bradley, C</creatorcontrib><creatorcontrib>Cooper, A</creatorcontrib><creatorcontrib>Munidasa, S</creatorcontrib><creatorcontrib>Zanette, B</creatorcontrib><creatorcontrib>Santyr, GE</creatorcontrib><creatorcontrib>Barr, H</creatorcontrib><creatorcontrib>Major, G</creatorcontrib><creatorcontrib>Smyth, A</creatorcontrib><creatorcontrib>Gowland, P</creatorcontrib><creatorcontrib>Francis, S</creatorcontrib><creatorcontrib>Hall, IP</creatorcontrib><title>L3 Structural and functional proton MRI assessment of cystic fibrosis lung disease in people with F508-del mutation</title><title>Thorax</title><description>IntroductionNewer proton MRI methods may be complementary to conventional respiratory diagnostics like computed tomography (CT) and spirometry. Non-contrast Ultrashort Echo Time (UTE) MRI acquires high resolution structural images, comparable to CT, and gradient-echo combined with phase-resolved functional lung (PREFUL) processing methods can produce spatial assessments of lung function. The need for such MRI methods is exemplified by cystic fibrosis (CF), where rapid development of novel therapeutics demands an equivalent change in our ability to monitor lung disease.AimTo evaluate lung structure and function using UTE and PREFUL MRI methods in people with CF with at least one F508-del mutation pre-Trikafta therapy.Methods5 people with CF (12–21 years; n=4 homozygous F508-del; n=3 on Symkevi) underwent a single MRI scanning session performed on a 3T Philips Ingenia scanner. UTE-MRI was collected during a 10-second breath-hold (n=2) or free breathing with a respiratory-gated acquisition (n=3). PREFUL-MRI was performed using a continuous single coronal slice Fast Field Echo acquisition during 2 minutes of free breathing (n=5).PREFUL analysis was performed using a semiautomated k-means segmentation algorithm in MATLAB. 1 A region of interest (ROI) at the diaphragm was defined, images with extremes of signal intensity were removed and those remaining sorted into a sinusoidal pattern of signal intensity within the ROI. Thoracic masking and a pulmonary vessel filter were applied followed by k-means clustering analysis to demonstrate normal ventilation and ventilation defect. Ventilation defect percentage (VDP) was calculated by dividing the ventilation defect volume by the lung mask volume.ResultsMRI scanning was well-tolerated and both UTE and PREFUL acquisitions were completed in all participants. VDP values ranged from 8.09–36.65%, with the individual with the lowest FEV1 having the highest VDP (figure 1).Abstract L3 Figure 1UTE (left) and PREFUL (right) images from five people with CF. PREFUL MRI shows areas of normal ventilation (green) and ventilation defect (purple).DiscussionOur findings demonstrate the feasibility of combined structural and functional lung MRI assessment in people with CF. These non-contrast approaches do not require additional specialised equipment, such as hyperpolarised gas, and could be obtained using standard clinical MRI scanners. In the future, functional lung MRI may facilitate longitudinal assessment of response to disease modifying therapies, such as CFTR modulators.ReferenceCouch, et al. Academic Radiology 2020. doi:10.1016/j.acra.2020.05.008.</description><subject>Cystic fibrosis</subject><subject>Lung diseases</subject><subject>Ventilation</subject><issn>0040-6376</issn><issn>1468-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpNkM1KAzEUhYMoWKvvENBt6s0kTTJLLVYLFcF2HzIzGZsynRnzg3bnxhf1SZxSF64uFw6H830I3VCYUMrEbdx03nySDDIg9-uVKUL0poxhwmF6gkaUC0VYlotTNALgQAST4hxdhLAFAEWpHKG0ZD9f36voUxmTNw02bYXr1JbRde3w9r6LXYufXxfYhGBD2Nk24q7G5T5EV-LaFb4LLuAmtW-4csGaYLFrcW-7vrH4w8UNnk9Bkco2eJeiORRforPaNMFe_d0xWs8f1rMnsnx5XMzulqSQgpGaWkVFzYFbqoRQuQJeqmF5UTDGBjrBaW5zI6kBnlEhJZecFpURuWGQcTZG18fageI92RD1tkt-wAo64zIXVABnQ0oeU8Vuq3vvdsbvNQV9UKyPivVBsf6vWA-K2S-_ynVm</recordid><startdate>202102</startdate><enddate>202102</enddate><creator>Brooke, J</creator><creator>Safavi, S</creator><creator>Prayle, AP</creator><creator>Ng, C</creator><creator>Alappadan, J</creator><creator>Bradley, C</creator><creator>Cooper, A</creator><creator>Munidasa, S</creator><creator>Zanette, B</creator><creator>Santyr, GE</creator><creator>Barr, H</creator><creator>Major, G</creator><creator>Smyth, A</creator><creator>Gowland, P</creator><creator>Francis, S</creator><creator>Hall, IP</creator><general>BMJ Publishing Group LTD</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>202102</creationdate><title>L3 Structural and functional proton MRI assessment of cystic fibrosis lung disease in people with F508-del mutation</title><author>Brooke, J ; Safavi, S ; Prayle, AP ; Ng, C ; Alappadan, J ; Bradley, C ; Cooper, A ; Munidasa, S ; Zanette, B ; Santyr, GE ; Barr, H ; Major, G ; Smyth, A ; Gowland, P ; Francis, S ; Hall, IP</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b763-f1e816f404e186689804c8008bb3331466419e9a71a04216774741bda69a30243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cystic fibrosis</topic><topic>Lung diseases</topic><topic>Ventilation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brooke, J</creatorcontrib><creatorcontrib>Safavi, S</creatorcontrib><creatorcontrib>Prayle, AP</creatorcontrib><creatorcontrib>Ng, C</creatorcontrib><creatorcontrib>Alappadan, J</creatorcontrib><creatorcontrib>Bradley, C</creatorcontrib><creatorcontrib>Cooper, A</creatorcontrib><creatorcontrib>Munidasa, S</creatorcontrib><creatorcontrib>Zanette, B</creatorcontrib><creatorcontrib>Santyr, GE</creatorcontrib><creatorcontrib>Barr, H</creatorcontrib><creatorcontrib>Major, G</creatorcontrib><creatorcontrib>Smyth, A</creatorcontrib><creatorcontrib>Gowland, P</creatorcontrib><creatorcontrib>Francis, S</creatorcontrib><creatorcontrib>Hall, IP</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Thorax</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brooke, J</au><au>Safavi, S</au><au>Prayle, AP</au><au>Ng, C</au><au>Alappadan, J</au><au>Bradley, C</au><au>Cooper, A</au><au>Munidasa, S</au><au>Zanette, B</au><au>Santyr, GE</au><au>Barr, H</au><au>Major, G</au><au>Smyth, A</au><au>Gowland, P</au><au>Francis, S</au><au>Hall, IP</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>L3 Structural and functional proton MRI assessment of cystic fibrosis lung disease in people with F508-del mutation</atitle><jtitle>Thorax</jtitle><date>2021-02</date><risdate>2021</risdate><volume>76</volume><issue>Suppl 1</issue><spage>A231</spage><epage>A232</epage><pages>A231-A232</pages><issn>0040-6376</issn><eissn>1468-3296</eissn><abstract>IntroductionNewer proton MRI methods may be complementary to conventional respiratory diagnostics like computed tomography (CT) and spirometry. Non-contrast Ultrashort Echo Time (UTE) MRI acquires high resolution structural images, comparable to CT, and gradient-echo combined with phase-resolved functional lung (PREFUL) processing methods can produce spatial assessments of lung function. The need for such MRI methods is exemplified by cystic fibrosis (CF), where rapid development of novel therapeutics demands an equivalent change in our ability to monitor lung disease.AimTo evaluate lung structure and function using UTE and PREFUL MRI methods in people with CF with at least one F508-del mutation pre-Trikafta therapy.Methods5 people with CF (12–21 years; n=4 homozygous F508-del; n=3 on Symkevi) underwent a single MRI scanning session performed on a 3T Philips Ingenia scanner. UTE-MRI was collected during a 10-second breath-hold (n=2) or free breathing with a respiratory-gated acquisition (n=3). PREFUL-MRI was performed using a continuous single coronal slice Fast Field Echo acquisition during 2 minutes of free breathing (n=5).PREFUL analysis was performed using a semiautomated k-means segmentation algorithm in MATLAB. 1 A region of interest (ROI) at the diaphragm was defined, images with extremes of signal intensity were removed and those remaining sorted into a sinusoidal pattern of signal intensity within the ROI. Thoracic masking and a pulmonary vessel filter were applied followed by k-means clustering analysis to demonstrate normal ventilation and ventilation defect. Ventilation defect percentage (VDP) was calculated by dividing the ventilation defect volume by the lung mask volume.ResultsMRI scanning was well-tolerated and both UTE and PREFUL acquisitions were completed in all participants. VDP values ranged from 8.09–36.65%, with the individual with the lowest FEV1 having the highest VDP (figure 1).Abstract L3 Figure 1UTE (left) and PREFUL (right) images from five people with CF. PREFUL MRI shows areas of normal ventilation (green) and ventilation defect (purple).DiscussionOur findings demonstrate the feasibility of combined structural and functional lung MRI assessment in people with CF. These non-contrast approaches do not require additional specialised equipment, such as hyperpolarised gas, and could be obtained using standard clinical MRI scanners. In the future, functional lung MRI may facilitate longitudinal assessment of response to disease modifying therapies, such as CFTR modulators.ReferenceCouch, et al. Academic Radiology 2020. doi:10.1016/j.acra.2020.05.008.</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1136/thorax-2020-BTSabstracts.405</doi></addata></record>
fulltext fulltext
identifier ISSN: 0040-6376
ispartof Thorax, 2021-02, Vol.76 (Suppl 1), p.A231-A232
issn 0040-6376
1468-3296
language eng
recordid cdi_proquest_journals_2479616043
source Alma/SFX Local Collection
subjects Cystic fibrosis
Lung diseases
Ventilation
title L3 Structural and functional proton MRI assessment of cystic fibrosis lung disease in people with F508-del mutation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T14%3A52%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_bmj_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=L3%E2%80%85Structural%20and%20functional%20proton%20MRI%20assessment%20of%20cystic%20fibrosis%20lung%20disease%20in%20people%20with%20F508-del%20mutation&rft.jtitle=Thorax&rft.au=Brooke,%20J&rft.date=2021-02&rft.volume=76&rft.issue=Suppl%201&rft.spage=A231&rft.epage=A232&rft.pages=A231-A232&rft.issn=0040-6376&rft.eissn=1468-3296&rft_id=info:doi/10.1136/thorax-2020-BTSabstracts.405&rft_dat=%3Cproquest_bmj_p%3E2479616043%3C/proquest_bmj_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2479616043&rft_id=info:pmid/&rfr_iscdi=true